24424-99-5 + 88930-14-7 = 89536-85-6 反应条件:1.1 Reagents: Sodium Carbonate Solvents: Acetone,Water; Rt 标题:Defining The Structural Parameters That Confer Anticonvulsant Activity By The Site-By-Site Modification Of (R)-N'-Benzyl 2-Amino-3-Methylbutanamide 作者:King,Amber M.; De Ryck,Marc; Kaminski,Rafal; Valade,Anne; Stables,James P.; Et Al 参考文献:Journal Of Medicinal Chemistry 日期:2011 卷标:54(19) 页码:6432-6442]
24424-99-5 + 640-68-6 = 89536-85-6 反应条件:1.1 Reagents: Sodium Hydroxide Solvents: 1,4-Dioxane,Water1.2 Solvents: Tetrahydrofuran 标题:Chemical Mediators: The Remarkable Structure And Host-Selectivity Of Depsilairdin,A Sesquiterpenic Depsipeptide Containing A New Amino Acid 作者:Pedras,M. Soledade C.; Chumala,Paulos B.; Quail,J. Wilson 参考文献:Organic Letters 日期:2004 卷标:6(24) 页码:4615-4617
Boc-D-缬氨酸,碘甲烷置于sodium Hydride体系中,用 四氢呋喃 作为反应溶剂,化学反应生成 Boc-N-甲基-D-缬氨酸 参考文献:Marine Cyclotripeptide X-13 Promotes Angiogenesis In Zebrafish And Human Endothelial Cells Via Pi3K/akt/enos Signaling Pathways 标题:Marine Cyclotripeptide X-13 Promotes Angiogenesis In Zebrafish And Human Endothelial Cells Via Pi3K/akt/enos Signaling Pathways 摘要:环三肽 X-13 是一种从红树林真菌 Xylaria Sp.(编号 2508)中分离出来的新型海洋化合物 Xyloallenoide A 的核心成分.我们发现,X-13 可剂量依赖性地诱导斑马鱼胚胎和人类内皮细胞的血管反应生成,同时增加 Enos 和 Akt 的磷酸化以及 No 的释放.用 Ly294002 或 L-Name 抑制 Pi3K/akt/enos 可抑制 X-13 诱导的血管反应生成.本研究表明,X-13通过pi3K/akt/enos途径促进血管反应生成. DOI:10.3390/md10061307
专利号:US-2004110228-A1 优先权日:2002-04-01 标 题:Combinatorial organic synthesis of unique biologically active compounds 发明人:MCALPINE SHELLI R; TAYLOR RACHEL E; BOLLA MEGAN L; SEGALL ANCA M 摘要:The invention provides a method for making a combinatorial library of cyclic compounds, such as Holliday junction-trapping compounds, comprising the steps of (a) obtaining a plurality of trimers according to the generic structure X 1- X 2- X 3 , wherein X 1 , X 2 and X 3 can be independently any naturally or nonnaturally occurring amino acids or peptidomimetics thereof; (b) optionally coupling a spacer S to the trimer at either end; (c) cyclizing two trimers or trimer-spacer conjugates in a head-to-tail orientation; thereby obtaining a combinatorial library of compounds, wherein the library does not include an unmodifed or naturally occurring Holliday Junction-trapping compounds. The invention additionally provides methods macrocyclic compounds that are synergimycin derivatives.